Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Pulmonary Hypertension
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Triple (Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Diagnostic
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04231084
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Aaron B Waxman, MD Brigham and Women's Hospital